Specialty molecules from plants and in vitro cultures as new drugs: regulatory considerations from flask to patient

Jinhui Dou, Pamela Weathers

Open source

DOI
10.1007/s11240-022-02287-4
Published
2022-03-23
Container
Plant Cell, Tissue and Organ Culture (PCTOC)
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11240-022-02287-4,
  title = {Specialty molecules from plants and in vitro cultures as new drugs: regulatory considerations from flask to patient},
  author = {Jinhui Dou and Pamela Weathers},
  year = {2022},
  journal = {Plant Cell, Tissue and Organ Culture (PCTOC)},
  doi = {10.1007/s11240-022-02287-4},
  url = {https://doi.org/10.1007/s11240-022-02287-4}
}

RIS

TY  - JOUR
TI  - Specialty molecules from plants and in vitro cultures as new drugs: regulatory considerations from flask to patient
AU  - Jinhui Dou
AU  - Pamela Weathers
PY  - 2022
JO  - Plant Cell, Tissue and Organ Culture (PCTOC)
DO  - 10.1007/s11240-022-02287-4
UR  - https://doi.org/10.1007/s11240-022-02287-4
ER  - 

APA

Dou, J., & Weathers, P. (2022). Specialty molecules from plants and in vitro cultures as new drugs: regulatory considerations from flask to patient. Plant Cell, Tissue and Organ Culture (PCTOC). https://doi.org/10.1007/s11240-022-02287-4

Source records